Download PDF
CC BY-NC-ND 4.0 · Avicenna J Med 2021; 11(04): 185-195
DOI: 10.1055/s-0041-1736542
Original Article

Practice Patterns for the Acceptance of Medically Complex Living Kidney Donors with Hematuria, Sickle Cell Trait, Smoking, Illegal Drug Use, or Urological Issues: A Multinational Survey

Ziad Arabi
1   Department of the Organ Transplant Center, Division of Adult Transplant Nephrology, King Abdulaziz Medical City, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
,
Abdullah Hamad 
2   Department of Medicine, Division of Nephrology, Regional Medical Center of Orangeburg and Calhoun Counties, Orangeburg, South Carolina, United Sates
,
Muhammad Bukhari 
3   Department of Medicine, Division of Adult Nephrology, Taif University, Taif, Saudi Arabia
,
Abdulrahman Altheaby 
1   Department of the Organ Transplant Center, Division of Adult Transplant Nephrology, King Abdulaziz Medical City, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
,
Saleh Kaysi
4   Department of Medicine, Division of Nephrology, CHU Clermont-Ferrand, France
› Author Affiliations Funding None
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background To review the practice patterns for the acceptance of medically complex living kidney donors (MCLKD) among the transplant providers of the international transplant community.

Methods We distributed a survey globally, through major international transplantation societies, among nephrologists and transplant surgeons (TS). The survey contained questions regarding potential donors with microscopic hematuria, sickle cell trait, renal cysts, kidney stones, smoking, or illegal drug use.

Results There were 239 respondents from 29 countries, including nephrologists (42%) and TS (58%). Although most respondents would investigate microscopic hematuria, one-third of them indicated they would decline these potential donors without investigation. Interestingly, most respondents accepted heavy smokers, intermittent illegal drug users (with advice to quit), and those with incidentally identified kidney stones, remote history of renal colic or simple renal cysts. We found multiple areas of consensus in practice with some interesting differences between nephrologists and TS.

Conclusions This survey highlights the practice patterns of the acceptance of MCLKDs among the international community. In the absence of clear guidelines, this survey provides additional information to counsel kidney donors with microscopic hematuria, sickle cell trait, renal cysts, kidney stones, heavy smoking, or illegal drug use.

Keywords

Drug Use - Extended criteria - Hematuria - kidney stone - Living kidney donor - Multi-national survey - renal cyst - sickle cell trait - smoking - Survey


Publication History

Article published online:
15 November 2021

© 2021. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Maggiore U, Cravedi P. The marginal kidney donor. Curr Opin Organ Transplant 2014; 19 (04) 372-380
    CrossrefPubMedGoogle Scholar
  • 2 Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008; 8 (10) 2062-2070
    CrossrefPubMedGoogle Scholar
  • 3 Maggiore U, Budde K, Heemann U. et al; ERA-EDTA DESCARTES working group. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group. Nephrol Dial Transplant 2017; 32 (02) 216-223
    CrossrefPubMedGoogle Scholar
  • 4 Muzaale AD, Massie AB, Wang M-C. et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311 (06) 579-586
    CrossrefPubMedGoogle Scholar
  • 5 Halverson CME, Wang JY, Poulson M, Karlin J, Crowley-Matoka M, Ross LF. Living kidney donors who develop kidney failure: excerpts of their thoughts. Am J Nephrol 2016; 43 (06) 389-396
    CrossrefPubMedGoogle Scholar
  • 6 Kiberd BA, Tennankore KK. Lifetime risks of kidney donation: a medical decision analysis. BMJ Open 2017; 7 (08) e016490
    CrossrefPubMedGoogle Scholar
  • 7 Abramowicz D, Cochat P, Claas FHJ. et al. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 2013; 28 (Suppl. 02) ii1-ii71
    CrossrefPubMedGoogle Scholar
  • 8 Lentine KL, Kasiske BL, Levey AS. et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017; 101 (8S): (Suppl. 01) S1-S109
    PubMedGoogle Scholar
  • 9 Abramowicz D, Cochat P, Claas FHJ. et al. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 2015; 30 (11) 1790-1797
    CrossrefPubMedGoogle Scholar
  • 10 ESRD Risk Tool for Kidney Donor Candidates. Accessed September 21, 2021 at: http://wwwtransplantmodelscom/esrdrisk/
  • 11 Grams ME, Sang Y, Levey AS. et al; Chronic Kidney Disease Prognosis Consortium. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2016; 374 (05) 411-421
    CrossrefPubMedGoogle Scholar
  • 12 Cantarelli C, Cravedi P. Criteria for living donation from marginal donors: one, no one, and one hundred thousand. Nephron 2019; 142 (03) 227-232
    CrossrefPubMedGoogle Scholar
  • 13 Lafranca JA, Spoon EQW, van de Wetering J, IJzermans JNM, Dor FJMF. Attitudes among transplant professionals regarding shifting paradigms in eligibility criteria for live kidney donation. PLoS One 2017; 12 (07) e0181846
    CrossrefPubMedGoogle Scholar
  • 14 Prevention CfDCa. Incidence of Sickle Cell Trait in the US. Accessed April 13, 2020 at: https://wwwcdcgov/ncbddd/sicklecell/features/keyfinding-traithtml
    Google Scholar
  • 15 Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med 2011; 31 (03) 289-293
    CrossrefPubMedGoogle Scholar
  • 16 Adam MA, Adam NK, Mohamed BA. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan. BMC Res Notes 2019; 12 (01) 659
    CrossrefPubMedGoogle Scholar
  • 17 Shabbir S, Nadeem M, Sattar A. et al. Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan. Cogent Med 2016; 3 (01) 1188875
    CrossrefGoogle Scholar
  • 18 Piel FB, Patil AP, Howes RE. et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010; 1 (01) 104
    CrossrefPubMedGoogle Scholar
  • 19 Hashmi NK, Moiz B, Nusrat M, Hashmi MR. Chromatographic analysis of Hb S for the diagnosis of various sickle cell disorders in Pakistan. Ann Hematol 2008; 87 (08) 639-645
    CrossrefPubMedGoogle Scholar
  • 20 Garg AX, Levey AS, Kasiske BL, Cheung M, Lentine KL. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team. Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice. Clin J Am Soc Nephrol 2020; 15 (06) 896-905
    CrossrefPubMedGoogle Scholar
  • 21 Kido R, Shibagaki Y, Iwadoh K. et al. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant 2010; 10 (07) 1597-1604
    CrossrefPubMedGoogle Scholar
  • 22 Hassan EA, Ali TZ, Abdulbaki A, Ibrahim IA, Almanae HM, Aleid HA. Histopathologic findings of potential kidney donors with asymptomatic microscopic hematuria: impact on donation. Transplant Proc 2017; 49 (08) 1729-1732
    CrossrefPubMedGoogle Scholar
  • 23 Choi SR, Sun IO, Hong YA. et al. The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities. Transplant Proc 2012; 44 (01) 11-13
    CrossrefPubMedGoogle Scholar
  • 24 Kumar V, Saha M, Hanaway M, Locke J, Julian B, Gaston R. Very low levels of microscopic hematuria in potential living kidney donors is associated with pathology that precludes donation. Transplantation 2018; 102: S138
    CrossrefGoogle Scholar
  • 25 Vadivel N, Stankovic A, Rennke HG, Singh AK. Accepting prospective kidney donors with asymptomatic urinary abnormalities: are we shooting in the dark?. Kidney Int 2007; 71 (02) 173-177
    CrossrefPubMedGoogle Scholar
  • 26 Imafuku A, Nozu K, Sawa N, Nakanishi K, Ubara Y. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists. Clin Exp Nephrol 2020; 24 (08) 651-656
    CrossrefPubMedGoogle Scholar
  • 27 Choi C, Ahn S, Min SK. et al. Midterm outcome of kidney transplantation from donors with thin basement membrane nephropathy. Transplantation 2018; 102 (04) e180-e184
    CrossrefPubMedGoogle Scholar
  • 28 Carasi C, Van't Hoff WG, Rees L, Risdon RA, Trompeter RS, Dillon MJ. Childhood thin GBM disease: review of 22 children with family studies and long-term follow-up. Pediatr Nephrol 2005; 20 (08) 1098-1105
    CrossrefPubMedGoogle Scholar
  • 29 Hartono C. Live Kidney Donors with Microscopic Hematuria. The Living Donor Community of Practice of AST. Accessed September 21, 2021 at: https://www.myast.org/sites/default/files/pdf/Chapter%208%20%20Microscopic%20hematuria%20in%20kidney%20donors.pdf
    Google Scholar
  • 30 Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med 2009; 122 (06) 507-512
    CrossrefPubMedGoogle Scholar
  • 31 Sesso R, Almeida MA, Figueiredo MS, Bordin JO. Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 1998; 31 (10) 1257-1262
    CrossrefPubMedGoogle Scholar
  • 32 Beckermann KE, Sharma D, Chaturvedi S. et al. Renal medullary carcinoma: establishing standards in practice. J Oncol Pract 2017; 13 (07) 414-421
    CrossrefPubMedGoogle Scholar
  • 33 Shaw C, Sharpe CC. Could sickle cell trait be a predisposing risk factor for CKD?. Nephrol Dial Transplant 2010; 25 (08) 2403-2405
    CrossrefPubMedGoogle Scholar
  • 34 Mukendi K, Lepira FB, Makulo JR, Sumaili KE, Kayembe PK, Nseka MN. Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study. Cardiovasc J Afr 2015; 26 (03) 125-129
    CrossrefPubMedGoogle Scholar
  • 35 Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol 2010; 21 (03) 413-417
    CrossrefPubMedGoogle Scholar
  • 36 Olaniran KO, Allegretti AS, Zhao SH. et al. Kidney function decline among black patients with sickle cell trait and sickle cell disease: an observational cohort study. J Am Soc Nephrol 2020; 31 (02) 393-404
    CrossrefPubMedGoogle Scholar
  • 37 Nath KA, Vercellotti GM. Renal functional decline in sickle cell disease and trait. J Am Soc Nephrol 2020; 31 (02) 236-238
    CrossrefPubMedGoogle Scholar
  • 38 Reese PP, Hoo AC, Magee CC. Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers. Transpl Int 2008; 21 (04) 328-331
    CrossrefPubMedGoogle Scholar
  • 39 Kitchlu A, Adhikari N, Burns KEA. et al. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study. BMC Nephrol 2015; 16: 127-127
    CrossrefPubMedGoogle Scholar
  • 40 Wilson D, Wakefield M, Owen N, Roberts L. Characteristics of heavy smokers. Prev Med 1992; 21 (03) 311-319
    CrossrefPubMedGoogle Scholar
  • 41 Killen JD, Fortmann SP, Telch MJ, Newman B. Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA 1988; 260 (11) 1581-1585
    CrossrefPubMedGoogle Scholar
  • 42 Aref A, Sharma A, Halawa A. Smoking in Renal Transplantation; Facts Beyond Myth. World J Transplant 2017; 7 (02) 129-133
    CrossrefPubMedGoogle Scholar
  • 43 Heldt J, Torrey R, Han D. et al. Donor smoking negatively affects donor and recipient renal function following living donor nephrectomy. Adv Urol 2011; 2011: 929263-929263
    CrossrefPubMedGoogle Scholar
  • 44 Underwood PW, Sheetz KH, Cron DC, Terjimanian MN, Englesbe MJ, Waits SA. Cigarette smoking in living kidney donors: donor and recipient outcomes. Clin Transplant 2014; 28 (04) 419-422
    CrossrefPubMedGoogle Scholar
  • 45 Donor Selection Criteria. UC Davis Health/ Transplant Center/ Living Donation. Accessed April 27, 2020 at: https://health.ucdavis.edu/transplant/livingdonation/donor_criteria.html
    Google Scholar
  • 46 Ruckle D, Keheila M, West B. et al. Should donors who have used marijuana be considered candidates for living kidney donation?. Clin Kidney J 2018; 12 (03) 437-442
    CrossrefPubMedGoogle Scholar
  • 47 Lin SJ, Koford JK, Baird BC. et al. Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome. Transplantation 2005; 80 (04) 482-486
    CrossrefPubMedGoogle Scholar
  • 48 Piccoli GB, Soragna G, Putaggio S. et al. Drug use and kidney donation: what are high-risk behaviors today?. Transplant Proc 2006; 38 (05) 1221-1223
    CrossrefPubMedGoogle Scholar
  • 49 Grotemeyer D, Voiculescu A, Iskandar F. et al. Renal cysts in living donor kidney transplantation: long-term follow-up in 25 patients. Transplant Proc 2009; 41 (10) 4047-4051
    CrossrefPubMedGoogle Scholar
  • 50 Simms RJ, Ong AC. How simple are 'simple renal cysts'?. Nephrol Dial Transplant 2014; 29 (Suppl. 04) iv106-iv112
    CrossrefPubMedGoogle Scholar
  • 51 Lorenz EC, Lieske JC, Vrtiska TJ. et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 2011; 26 (08) 2695-2700
    CrossrefPubMedGoogle Scholar
  • 52 Tatapudi VS, Goldfarb DS. Differences in national and international guidelines regarding use of kidney stone formers as living kidney donors. Curr Opin Nephrol Hypertens 2019; 28 (02) 140-147
    CrossrefPubMedGoogle Scholar
  • 53 Serur D, Charlton M, Juluru K. et al. Long term follow up of kidney donors with asymptomatic renal stones. Nephrology (Carlton) 2017; 22 (08) 649-651
    CrossrefPubMedGoogle Scholar
  • 54 Serur D. Should kidney donors with asymptomatic small stones be allowed to donate?. Living Donor Community of Practice of AST. Accessed September 21, 2021 at: https://www.myast.org/sites/default/files/pdf/Chapter%206%20%20%20Donors%20with%20stones.pdf
    Google Scholar
  • 55 Delmonico F. Council of the Transplantation Society. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation 2005; 79 (6, Suppl) S53-S66
    CrossrefPubMedGoogle Scholar
  • 56 Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. The evaluation of living renal transplant donors: clinical practice guidelines. J Am Soc Nephrol 1996; 7 (11) 2288-2313
    CrossrefPubMedGoogle Scholar
  • 57 (OPTN) OPaTN. Organ Procurement and Transplantation Network (OPTN) Policies. Accessed April 12, 2020 at: https://optntransplanthrsagov/media/1200/optn_policiespdf#nameddest=Policy_14
    Google Scholar
  • 58 MD CbQ. Predict risk of recurrent kidney stones. Accessed September 21, 2021 at: https://qxmd.com/calculate/calculator_3/roks-recurrence-of-kidney-stone-2014
    Google Scholar
  • 59 Shokeir AA, Gad HM, el-Diasty T. Role of radioisotope renal scans in the choice of nephrectomy side in live kidney donors. J Urol 2003; 170 (2 Pt 1): 373-376
    CrossrefPubMedGoogle Scholar
  • 60 Oh CK, Yoon SN, Lee BM. et al. Routine screening for the functional asymmetry of potential kidney donors. Transplant Proc 2006; 38 (07) 1971-1973
    CrossrefPubMedGoogle Scholar
  • 61 Habbous S, Woo J, Lam NN. et al. The efficiency of evaluating candidates for living kidney donation: a scoping review. Transplant Direct 2018; 4 (10) e394-e394
    CrossrefPubMedGoogle Scholar
  • 62 Habbous S, Garcia-Ochoa C, Brahm G, Nguan C, Garg AX. Can split renal volume assessment by computed tomography replace nuclear split renal function in living kidney donor evaluations? A systematic review and meta-analysis. Can J Kidney Health Dis 2019; 6: 2054358119875459
    CrossrefPubMedGoogle Scholar
  • 63 Tanriover B, Fernandez S, Campenot ES. et al. Live donor renal anatomic asymmetry and posttransplant renal function. Transplantation 2015; 99 (08) e66-e74
    CrossrefPubMedGoogle Scholar
  • 64 Wright L, Faith K, Richardson R, Grant D. Joint Centre for Bioethics, University of Toronto, Toronto, Ont. Ethical guidelines for the evaluation of living organ donors. Can J Surg 2004; 47 (06) 408-413
    PubMedGoogle Scholar
  • 65 Searing L. The Big Number: 39,717 organ transplants in the U.S. last year. Accessed March 2, 2020 at: https://wwwwashingtonpostcom/health/the-big-number-39717-organ-transplants-in-the-us-last-year/2020/02/28/2f9c376e-5976-11ea-9000-f3cffee23036_storyhtml
    Google Scholar
  • 66 Organisation TSNT. World Transplant Registry reports 139,024 transplants performed worldwide last year, up 2.3%. Accessed June 24, 2020 at: https://wwwlamoncloagobes/lang/en/gobierno/news/Paginas/2019/20180828transplantaspx#:~:text=In%20total%2C%203%2C313%20kidney%20transplants,six%20intestinal%20transplants%20were%20performed
    Google Scholar